Therapeutic uses of bactericidal/permeability increasing protein

Details Therapeutic uses of bactericidal/permeability increasing protein Therapeutic uses of bactericidal/permeability increasing protein

1993-03-12

1994-09-20

Furman, Keith C.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 21, 514 13, 514 14, 514 15, A61K 3702

Patent

active

053489420

ABSTRACT:
The present invention provides therapeutic methods for treatment of conditions including the neutralization of the anti-coagulant activity of heparin, inhibition of angiogenesis, tumor and endothelial cell proliferation, and treatment of chronic inflammatory diseases by administration of bactericidal/permeability-increasing (BPI) protein products.

REFERENCES:
patent: 5086164 (1992-02-01), Maione et al.
patent: 5112946 (1992-05-01), Maione
patent: 5171739 (1992-12-01), Scott et al.
Mannion et al. Mar. 1990. J. Clin Invest. 85:853-860.
Weiss et al. 1978. J. Biol. Chem. 253(8): 2664-2672.
Charles, et al., J. Biol. Chem., "The Three-dimensional Structure of Bovine Platelet Factor 4 at 3.0-.ANG. Resolution," 264(4): 2092-2099 (Feb. 5, 1989).
Cook, et al., Circulation, "Platelet Factor 4 Efficiently Reverses Heparin Anticoagulation in the Rat Without Adverse Effects of Heparin-Protamine Complexes," 85(3): 1102-1109 (Mar. 1992).
Elsbach, et al., J. Biol. Chem., "Separation and Purification of a Potent Bactericidal/Permeability-increasing Protein and a Closely Associated Pospholipase A.sub.2 from Rabbit Polymorphonuclear Leukocytes," 254(21): 11000-11009 (Nov. 10, 1979).
Folkman, et al., Inflammation: Basic Principles and Clinical Correlates, "Angiogenesis and Inflammation," 2nd Ed. Chapter 40, pp. 821-839 (1992).
Gammon, et al., J. Exp. Med, "T Cell Determinant Structure: Cores and Determinant Envelopes in Three Mouse Major Histocompatibility Complex Haplotypes," 173: 609-617 (Mar. 1991).
Garcia, et al., BioWorld Today, "Repligen IND for Platelet Factor" p. 5 (Jan. 11, 1983).
Gazzano-Santoro, et al., Infect. Immunol., "High-Affinity Binding of the Bactericidal/Permeability Increasing Protein and a Recombinant Amino-Terminal Fragment to the Lipid A Region of Lipopolysaccharide," 60(11):4754-4761 (Nov., 1992).
Gray, et al., J. Biol. Chem., "Cloning of the cDNA of a Human Neutrophil Bactericidal Protein," 264(16): 9505-9509 (Jun. 5, 1989).
Heyderman, et al., Thrombosis Res., "Reduction of the Anticoagulant Activity of Glycosaminoglycans on the Surface of the Vascular Endothelium by Endotoxin and Neutrophils: Evaluation by an Amidolytic Assay," 67:677-685 (Apr. 28, 1992).
Hiti-Harper, et al., Science,. "Platelet Factor 4: An Inhibitor of Collagenase," 199:991-992 (Mar. 3, 1978).
Maeji, et al., J. Immunological Methods, "Multi-pin peptide strategy for T cell determinant analysis," 134:23-33 (1990).
Maione , et al., Cancer Res., "Inhibition of Tumor Growth in Mice by an Analogue of Platelet Factor 4 That Lacks Affinity for Heparin and Retains Potent Angiostatic Activity," 51:2077-2083 (Apr. 15, 1991).
Maione, et al., CAS BioTech Updates-Antibody Conjugates, p. 1, 1334, 117:226303x Issue Jun. 26, 1992).
Miles, et al., VII International Conference on Aids, Florence, Italy, "Recombinant Platelet Factor 4 (rPF4) and a Non-heparin Binding Derivative Inhibit Aids-Kaposi Sarcoma Derived Cell Lines," Paper 41(8), W.A. 1066, p. 108 (Jun. 16-21, 1991).
Peacock, et al., J. Exp. Med., "Angiogenesis Inhibition Suppresses Collagen Arthritis," 175: 1135-1138 (Apr., 1992).
Repligen Corporation, Research in Review, Spring 1992.
Stuart, et al., J. Clin. Invest., "Nature and Specificity of the Immune Response to Collagen in Type II Collagen-induced Arthritis in Mice" 69: 673-683 (Mar., 1982).
Taylor, et al., Nature, "Protamine is an inhibitor of angiogenesis," 297: 307-312 (May 27, 1982).
Weiss, et al., Blood, "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils," 69(2): 652-659 (Feb., 1987).
Yayon, et al., Cell, "Cell Surface, Heparin-like Molecules Are Required for Binding of Basis Fibroblast Growth Factor to Its High Affinity Receptor," 64: 641-648 (Feb. 22, 1991).
Yong, et al., Microbial Pathogenesis, "An experimental mouse model of Yersinia-induced reactive arthritis," 4: 305-310 (1988).

Affiliated with

Also associated with

Rating

Therapeutic uses of bactericidal/permeability increasing protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic uses of bactericidal/permeability increasing protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of bactericidal/permeability increasing protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2429871